2A Pharma ApS: Financial statements 2022
CVR: 39391597
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -210,110 and a net result of DKK -1,523,981 compared with DKK 271,693 the year before. Equity in the 2022 report amounted to DKK -585,511. The company had 2 employees in the financial year.
- Gross Profit
- DKK -210,110
- Profit/Loss
- DKK -1,523,981
- Equity
- DKK -585,511
- Total Assets
- DKK 1,309,029
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -210 t. | -1.5 mio. | -586 t. | 2 |
| 2021 | - | 1.9 mio. | 272 t. | 938 t. | 2 |
| 2020 | - | 2.1 mio. | 322 t. | 667 t. | 3 |
| 2019 | - | 1.5 mio. | -81 t. | 344 t. | 1 |
| 2018 | - | 947 t. | -60 t. | 426 t. | 1 |
Keep an eye on 2A Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
2A Pharma ApS has published its annual report for 2021. Gross profit came to DKK 1,948,298, and the net result was DKK 271,693.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.